Acute Treatment of Bipolar II Depression

Not Recruiting

Trial ID: NCT00074776


This study will compare the medications lithium and lamotrigine (Lamictal®) in treating depression in individuals with bipolar II disorder.

Official Title

Acute Treatment of Bipolar II Depression

Stanford Investigator(s)

Trisha Suppes, MD, PhD
Trisha Suppes, MD, PhD

Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)


Inclusion Criteria:

* Current diagnosis of bipolar II disorder

Exclusion Criteria:

* Use of lithium or lamotrigine
* Intolerance to lithium or lamotrigine
* Substance abuse or dependence within the last month
* Suicidal thoughts
* Unstable medical conditions
* Pregnancy or breast-feeding
* Stable on current medications
* Use of fluoxetine (Prozac) within 2 weeks of study
* Require an antipsychotic medication
* Do not speak or read English


drug: Lithium

drug: Lamotrigine

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305